benzyl isothiocyanate has been researched along with Diabetes Mellitus, Type 2 in 1 studies
benzyl isothiocyanate: inhibits carcinogen-induced neoplasia; structure in Negwer, 5th ed, #715; also promotes urinary bladder carcinoma
Diabetes Mellitus, Type 2: A subclass of DIABETES MELLITUS that is not INSULIN-responsive or dependent (NIDDM). It is characterized initially by INSULIN RESISTANCE and HYPERINSULINEMIA; and eventually by GLUCOSE INTOLERANCE; HYPERGLYCEMIA; and overt diabetes. Type II diabetes mellitus is no longer considered a disease exclusively found in adults. Patients seldom develop KETOSIS but often exhibit OBESITY.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Guzmán-Pérez, V | 1 |
| Bumke-Vogt, C | 1 |
| Schreiner, M | 1 |
| Mewis, I | 1 |
| Borchert, A | 1 |
| Pfeiffer, AF | 1 |
1 other study available for benzyl isothiocyanate and Diabetes Mellitus, Type 2
| Article | Year |
|---|---|
Benzylglucosinolate Derived Isothiocyanate from Tropaeolum majus Reduces Gluconeogenic Gene and Protein Expression in Human Cells.
Topics: Acetylcysteine; Active Transport, Cell Nucleus; Antioxidants; Cell Line; Cell Survival; Diabetes Mel | 2016 |